Hoth Therapeutics, Inc.
USD0.81
-0.03 (-4.09%)
CEO
Robb Knie
IPO Date
2019-02-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.83
Prev. Close
$0.85
Day Low
$0.81
Day High
$0.84
52W Low
$0.49
52W High
$2.45
Market Cap
$0.01B
Volume
0.52M
| 310,744 |
| $1.21 |
| 21 May 2025 | Camarra Christopher Michael | director: | Disposed | 0 | $0.00 |
| 15 Jan 2025 | Knie Robb | director, officer: CEO and President | A-Award | Acquired | 93,000 | $1.55 |
| 15 Jan 2025 | Knie Robb | director, officer: CEO and President | A-Award | Acquired | 7,000 | $1.55 |
| 15 Jan 2025 | Springer Graig | director | A-Award | Acquired | 70,000 | $1.55 |
| 21 Aug 2024 | Knie Robb | director, officer: CEO and President | A-Award | Acquired | 325,000 | $0.75 |
| 21 Aug 2024 | Springer Graig | director | A-Award | Acquired | 48,000 | $0.75 |
| 21 Aug 2024 | Springer Graig | director | A-Award | Acquired | 25,000 | $0.75 |
| 21 Aug 2024 | Linsley Wayne | director | A-Award | Acquired | 25,000 | $0.75 |